GoodRx Holdings, Inc.
GDRX
$3.31
-$0.06-1.78%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.05% | 2.21% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.05% | 2.21% | |||
| Cost of Revenue | -0.10% | 9.60% | |||
| Gross Profit | 0.06% | 1.73% | |||
| SG&A Expenses | 3.18% | 13.14% | |||
| Depreciation & Amortization | -5.66% | 9.51% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.62% | 9.46% | |||
| Operating Income | -3.53% | -27.89% | |||
| Income Before Tax | 17.45% | 46.10% | |||
| Income Tax Expenses | 19.91% | 20.28% | |||
| Earnings from Continuing Operations | 16.21% | 63.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 16.21% | 63.98% | |||
| EBIT | -3.53% | -27.89% | |||
| EBITDA | -4.44% | 16.31% | |||
| EPS Basic | 23.71% | 64.41% | |||
| Normalized Basic EPS | -1.15% | -33.27% | |||
| EPS Diluted | 23.71% | 64.41% | |||
| Normalized Diluted EPS | -1.15% | -33.01% | |||
| Average Basic Shares Outstanding | -5.95% | -0.63% | |||
| Average Diluted Shares Outstanding | -5.93% | -1.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||